San Diego, CA, United States of America

Mark Westerman


 

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 20(Granted Patents)


Location History:

  • San Diego, CA (US) (2010 - 2019)
  • La Jolla, CA (US) (2020 - 2021)

Company Filing History:


Years Active: 2010-2021

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Mark Westerman: Innovator in Biomedicine

Introduction

Mark Westerman is a prominent inventor based in San Diego, California. He has made significant contributions to the field of biomedicine, particularly in the development of antibodies for medical applications. With a total of nine patents to his name, Westerman's work has the potential to impact disease diagnosis and monitoring.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Antibodies to human erythroferrone and uses thereof." This patent discloses antibodies that are specific for erythroferrone, along with assays that incorporate these antibodies. The methods outlined in this patent are designed for the diagnosis or monitoring of various diseases, showcasing Westerman's innovative approach to medical science.

Career Highlights

Throughout his career, Mark Westerman has worked with notable organizations such as Intrinsic Lifesciences LLC and Austin Health. His experience in these companies has allowed him to refine his expertise and contribute to significant advancements in the biomedical field.

Collaborations

Westerman has collaborated with talented individuals in his field, including Vaughn Ostland and Huiling Han. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Mark Westerman's contributions to biomedicine through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to pave the way for advancements in disease diagnosis and treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…